Open Access

[Corrigendum] Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma

  • Authors:
    • Zhigang Yi
    • Yanchuan Pu
    • Ruoyan Gou
    • Yonggang Chen
    • Xiaojun Ren
    • Wenzhong Liu
    • Ping Dong
  • View Affiliations

  • Published online on: January 4, 2022     https://doi.org/10.3892/mmr.2022.12585
  • Article Number: 69
  • Copyright : © Yi et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

February-2022
Volume 25 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yi Z, Pu Y, Gou R, Chen Y, Ren X, Liu W and Dong P: [Corrigendum] Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma. Mol Med Rep 25: 69, 2022
APA
Yi, Z., Pu, Y., Gou, R., Chen, Y., Ren, X., Liu, W., & Dong, P. (2022). [Corrigendum] Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma. Molecular Medicine Reports, 25, 69. https://doi.org/10.3892/mmr.2022.12585
MLA
Yi, Z., Pu, Y., Gou, R., Chen, Y., Ren, X., Liu, W., Dong, P."[Corrigendum] Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma". Molecular Medicine Reports 25.2 (2022): 69.
Chicago
Yi, Z., Pu, Y., Gou, R., Chen, Y., Ren, X., Liu, W., Dong, P."[Corrigendum] Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma". Molecular Medicine Reports 25, no. 2 (2022): 69. https://doi.org/10.3892/mmr.2022.12585